Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KDR | P35968 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | TNF | P01375 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29662013 | 1.00 | CA1 (0.61) | CA1CA2PTGS2CA12ALOX5 | |
| SCHEMBL9488619 | 0.96 | CA1 (0.57) | CA1CA2PTGS2CA12ALOX5 | |
| Methacrylic Acid SCHEMBL28616220 | 0.87 | CSNK2A1 (0.50) | CA1CA2PTGS2CA12ALOX5 | |
| SCHEMBL980376 | 0.82 | ALDH1A1 (0.61) | CA1CA2PTGS2CA12ALOX5 | |
| SCHEMBL21383209 | 0.82 | EGFR (0.46) | CA1CA2PTGS2CA12ALOX5 | |
| SCHEMBL522679 | 0.81 | PTPN1 (0.55) | CA1CA2CA12CA7CA9 | |
| SCHEMBL23242473 | 0.80 | AR (0.47) | CA1CA2PTGS2CA12ALOX5 | |
| SCHEMBL4037170 | 0.80 | AR (0.47) | CA1CA2PTGS2CA12ALOX5 | |
| SCHEMBL11449959 | 0.80 | AR (0.47) | CA1CA2PTGS2CA12ALOX5 | |
| SCHEMBL30832900 | 0.80 | AR (0.47) | CA1CA2PTGS2CA12ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 767 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118619869-B | Halogen-containing lithium ion eutectic crystal and preparation method and application thereof | 佛山大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118619869-A | Halogen-containing lithium ion eutectic crystal and preparation method and application thereof | 佛山大学 | 2024-09-10 | — | — | CN | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-114113370-B | Analysis method of aromatic halogenated disinfection byproducts in water | 东南大学 | 2024-03-26 | — | — | CN | claimed |
| CN-114605277-B | Synthesis method of mesalazine | 宁波怡和医药科技有限公司 | 2022-10-11 | — | — | CN | claimed |
| US-11453600-B2 | Method of making hydrocarbon soluble metal compositions | INDIAN OIL CORPORATION LIMITED (IN) | 2022-09-27 | — | — | US | claimed |
| EP-3581635-B1 | HYDROCARBON SOLUBLE METAL COMPOSITIONS AND METHOD OF MAKING THEM | INDIAN OIL CORP LTD (IN) | 2022-08-03 | — | — | EP | claimed |
| CN-114605277-A | Synthesis method of mesalazine | 宁波怡和医药科技有限公司 | 2022-06-10 | — | — | CN | claimed |
| CN-114113370-A | Analysis method of aromatic halogenated disinfection byproducts in water | 东南大学 | 2022-03-01 | — | — | CN | claimed |
| CN-112276412-A | Laser welding solder paste and preparation method thereof | 苏州恩斯泰金属科技有限公司 | 2021-01-29 | — | — | CN | claimed |
| EP-0070198-B1 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMATION METHOD USING THE SAME | Hitachi, Ltd. (JP) | 1985-06-19 | — | — | EP | claimed |
| EP-0031561-B1 | A RECTALLY ADMINISTERED SUPPOSITORY COMPRISING A DRUG AND AN ADJUVANT | MERCK & CO. INC. (US) | 1985-04-10 | — | — | EP | claimed |
| US-4470980-A | Method of increasing oral absorption of β-lactam antibiotics | INTERX RESEARCH CORP. (US) | 1984-09-11 | — | — | US | claimed |
| US-4464363-A | HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS | MERCK & CO., INC. (US) | 1984-08-07 | — | — | US | claimed |
| US-4406896-A | ANTIBIOTICS, ACIDS, HYDROXY | MERCK & CO., INC. (US) | 1983-09-27 | — | — | US | claimed |
| EP-0070198-A1 | Radiation-sensitive composition and pattern-formation method using the same | Hitachi, Ltd. (JP) | 1983-01-19 | — | — | EP | claimed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |